Risk factors and chemoprevention in Barrett's esophagus – an update
- 10 January 2012
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 47 (4) , 397-406
Abstract
Objective. Barrett's esophagus (BO) is a precursor of esophageal adenocarcinoma (OAC), a cancer with a poor prognosis and an increasing incidence. Hence there is an interest in mapping causal factors underlying BO and finding strategies to reduce the risk of dysplasia progression in patients with BO. Here we review current knowledge on established as well as less risk factors for the development of BO. Additionally, we summarize today's status on the use of chemoprevention aiming to reduce the risk of cancer progression in BO patients. Methods. We searched Medline and the Cochrane Library using the MeSH terms “Barrett's esophagus” and “Barrett esophagus,” both alone and combined with the terms “risk factor,” “aetiology,” “diet,” or “prevention.” Focus was on original contributions, systematic reviews, and meta-analyses. Results. Established risk factors for the development of BO include gastro-esophageal reflux, obesity, male gender, Caucasian ethnicity, and increasing age. Smoking might increase the risk of BO, while aspirin/NSAIDs, Helicobacter pylori infection, and specific “healthy” dietary factors may lower the risk. The potential value of using chemoprevention with proton pump inhibitors, aspirin/NSAIDs, or statins is still uncertain. Conclusions. There is today a substantial knowledge of risk factors of BO. Certain diet may be protective of BO, albeit yet to be proven. The efficiency of chemoprevention in BO is currently addressed further in randomized clinical trials.Keywords
This publication has 96 references indexed in Scilit:
- Serum Leptin and Adiponectin Levels and Risk of Barrett's Esophagus and Intestinal Metaplasia of the Gastroesophageal JunctionObesity, 2010
- Medications (NSAIDs, Statins, Proton Pump Inhibitors) and the Risk of Esophageal Adenocarcinoma in Patients With Barrett's EsophagusGastroenterology, 2010
- History, Molecular Mechanisms, and Endoscopic Treatment of Barrett's EsophagusGastroenterology, 2010
- Medication Usage and the Risk of Neoplasia in Patients With Barrett's EsophagusClinical Gastroenterology and Hepatology, 2009
- Risk Factors for Barrett's Esophagus Among Patients With Gastroesophageal Reflux Disease: A Community Clinic-Based Case–Control StudyAmerican Journal of Gastroenterology, 2009
- Alcohol Types and Sociodemographic Characteristics as Risk Factors for Barrett's EsophagusGastroenterology, 2009
- Cigarette smoking and the risk of Barrett’s esophagusCancer Causes & Control, 2008
- Sex-specific risk factor profile in oesophageal adenocarcinomaBritish Journal of Cancer, 2008
- Helicobacter pylori and Gastroesophageal Reflux Disease: A Case–Control StudyHelicobacter, 2008
- Incidence of carcinoma of the oesophagus and gastric cardia. Changes over time and geographical differences.Acta Oncologica, 2007